SENTRUM REISEMEDISIN GRIMSTAD AS
Reisemedisin - Vaksinasjonsklinikker i Bergen, Oslo, Grimstad & Voss
Organization
- CEO
- PL
- Chairman of the board
- PL
- Years since formation
- 16 years
- since Oct 14, 2009
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 13
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 7,824,848
- NOK
- Annual total result 2024
- -370,980
- NOK
- Total equity 2024
- 308,773
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
PL | Managing Director/CEO | 50.98 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
PL | Chairman | 50.98 % indirectly |
BS 1963 | Board Member | - |
HS 1975 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - | |
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
PL | Managing Director/CEO, Chairman | 50.98 % indirectly |
EB 1976 | - | 49.02 % indirectly |
Last update: Nov 6, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 10,941,198Operating profit 2024: NOK 539,096Employees: 12
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 7,824,848 | 5,487,091 | 4,131,258 | 3,795,649 |
Annual Total Result | -370,980 | -165,314 | 52,060 | 371,940 |
Total assets | 1,632,404 | 1,980,366 | 2,455,519 | 3,441,101 |
Total liabilities | 1,323,631 | 865,213 | 1,088,446 | 2,126,089 |
Total equity | 308,773 | 1,115,153 | 1,367,073 | 1,315,013 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 7,824,848 | 5,487,091 | 4,131,258 | 3,795,649 |
Total operating costs | 8,262,880 | 5,664,008 | 4,064,566 | 3,414,684 |
Operating result | -438,031 | -176,917 | 66,692 | 380,965 |
Financial income/costs | -11,269 | 11,603 | 51 | -5,900 |
Profit before tax | -449,300 | -165,314 | 66,743 | 375,065 |
Total tax & extraordinary income/cost | -78,320 | 0 | 14,683 | 3,125 |
Annual Total Result | -370,980 | -165,314 | 52,060 | 371,940 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 56,036 | 56,613 | 8,873 |
Total current assets | 1,632,403 | 1,924,330 | 2,398,906 | 3,432,229 |
Total assets | 1,632,404 | 1,980,366 | 2,455,519 | 3,441,101 |
Short term debt | 1,323,631 | 865,213 | 1,088,446 | 1,413,092 |
Long term debt | 0 | 0 | 0 | 712,996 |
Total liabilities | 1,323,631 | 865,213 | 1,088,446 | 2,126,089 |
Contributed capital | 308,773 | 141,906 | 141,906 | 141,906 |
Retained earnings | 0 | 973,247 | 1,225,167 | 1,173,107 |
Total equity | 308,773 | 1,115,153 | 1,367,073 | 1,315,013 |
Total equity and liabilities | 1,632,404 | 1,980,366 | 2,455,519 | 3,441,101 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises